Türkiye vs Western Asia: Proportion of the target population who received a 3rd dose of
Türkiye
95.0%
in 2024
Western Asia
62.0%
in 2024
Türkiye rank
28th
Western Asia rank
26th
Proportion of the target population who received a 3rd dose of over time
- Türkiye
- Western Asia
How they compare
Türkiye currently reports 95.0% against 62.0% in Western Asia, a difference of 33.0%.
That makes Türkiye's figure about 1.5 times Western Asia's.
Across all 16 years both countries report, Türkiye has been ahead every year.
Türkiye ranks 28th and Western Asia ranks 26th of 157 countries.
Türkiye has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Türkiye | Western Asia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.0% | 35.0% | 62.0% | Türkiye |
| 2010s | 96.4% | 54.7% | 41.7% | Türkiye |
| 2020s | 95.2% | 55.6% | 39.6% | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Türkiye or Western Asia?
- Türkiye, at 95.0% against 62.0% in Western Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Türkiye and Western Asia?
- 33.0%, with Türkiye ahead.
- How many years of comparable data are there for Türkiye and Western Asia?
- 16 years are reported by both, from 2009 to 2024.
- How do Türkiye and Western Asia rank globally for proportion of the target population who received a 3rd dose of?
- Türkiye ranks 28th and Western Asia ranks 26th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.